NanaBis™


Cannabis Oil Extract, submicron particles in a oro-buccal spray


THC and CBD NanoCelle® - Late Stage Drug

Cannabis-based medicines general information

This page is intended to educate and provide general information on medicinal cannabis and its use for medical reasons when conventional therapies have failed. Here you also have information about the human endocannabinoid system and its interaction with cannabinoids, as well as information on how to access unregistered products.

Medlab has created a cannabis-based medication, NanaBis™, that is currently under investigation. If you’re wondering whether this cannabis-based medicine might be right for your condition, your first step is to have a conversation with your doctor or book an appointment for a screening consultation to evaluate if you are an eligible patient.

Book an appointment for a screening consultation

Joseph has achieved a Bachelor of Medical Science at the University of Technology Sydney and a Masters of Pharmacy at the University of Sydney. He has been a registered Pharmacist for over 10 years, having worked as a Hospital Clinical Pharmacist and a Medical Information Associate in Pharmaceuticals.

Joseph also currently works as a Community Pharmacist. His focus and passion are to provide empathetic, accurate and concise education to patients and healthcare professionals whilst maintaining and updating his medical knowledge.

BOOK NOW

Cannabis for Pain

An observational study is investigating and auditing the safety and further efficacy of pharmaceutical-grade cannabis 1:1 THC 8.93mg/ml and CBD 8.93mg/ml prescribed to eligible patients for the management of cancer or non—cancer-related pain in general and specialty medical practices.

Eligibility Requirements:

  • Age 18+
  • GP or specialist has indicated treatment with Medlab product
  • The patient can legally be prescribed
  • Patients must refrain from using other cannabis products

The study:

  • Up to 12 months’ duration
  • Prescribing doctor to submit 1 de-identifies patient report per month
  • The patient receives Medlab product at subsidised price

*Study approved by the National Institute of Integrative Medicine (NIIM) Human Research Ethics Committee, Approval ID 0052E_2019

For full eligibility requirements and further information: obs_study@medlab.co  or 02 8317 5453 - 02 83175452

Human Endocannabinoid System

The endocannabinoid system (ECS) plays a very important role in maintaining homeostasis in the human body. It is ubiquitous throughout our bodies. To begin with, it is a retrograde system functioning post- to pre-synapse, allowing it to be a “master regulator” in the body. Secondly, it has a very wide scope of influence due to an abundance of cannabinoid receptors located anywhere from immune cells to neurons. Finally, cannabinoids are rapidly synthesized and degraded, so they do not stay in the body for very long in high amounts, possibly enabling cannabinoid therapy to be a safer alternative to opioids or benzodiazepines.

We have (at least) two types of cannabinoid receptors:

  • CB1 which is in the central nervous system (brain and nerves of the spinal cord)
  • CB2 which is in the peripheral nervous system (nerves in your extremities), the digestive system, and specialized cells in the immune system.

Through these receptors, the ECS helps to regulate functions like appetite, inflammation, and pain!1

Cannabinoids

Cannabinoids are chemical compounds that trigger cannabinoid (and other) receptors found in the endocannabinoid system. The cannabis plant produces over 100 different cannabinoids. The two main cannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).2

Human Endocannabinoid System

How to access an unregistered cannabis-based product?

This Video provides information about how the TGA provides safe and legal access to medicinal cannabis products in appropriate circumstances. TGA has useful resources to help you navigate the special access scheme for the access of unregistered drugs that are currently under investigation. Individual consumers cannot apply to the TGA to obtain access to unapproved medicinal cannabis products. Access can only be arranged through an Australian registered health practitioner. Approval or authorisation is granted on a case-by-case basis. This work is copyrighted and belongs to TGA

TGA infographic - How to access medicinal cannabis

TGA How to Access Medicinal Cannabis

For specific product information please log in as Doctor.

DOCTOR LOGIN TO VIEW